Liver diseases are a worldwide medical problem because the liver is the principal
detoxifying organ and maintains metabolic homeostasis. The liver metabolizes various …

Hepatic disorders are considered major health problems, due to their high incidence,
increased risk of chronicling or death and the costs involved in therapies. A large number of …

The liver, as a central metabolic organ, is systemically linked to metabolic–inflammatory
diseases. In the pathogenesis of the metabolic syndrome, inflammatory and metabolic …

Increasing prevalence of nonalcoholic fatty liver disease (NAFLD) in parallel with the obesity
epidemic has been a major public health concern. NAFLD is the most common chronic liver …

This study aimed at investigating the chemical composition and the hepatoprotective
activities of Plumbago indica L. and P. auriculata Lam. LC–MS/MS analyses for the …

Silymarin, which is derived from the seeds of Silybum marianum, has been widely used to
prevent and treat liver disorders. It is also consumed as a dietary supplement to improve …

Tissue fibrosis underlies the majority of human mortality to date with close to half of all
reported deaths having a fibrotic etiology. The progression of fibrosis is very complex and …

Exposure to metallic nanoparticles (NPs) can result in inadvertent NP accumulation in body
tissues. While their subsequent cellular interactions can lead to unintended consequences …

Liver fibrosis is a health concern that leads to organ failure mediated via production of
inflammatory cytokines and fibrotic biomarkers. This study aimed to explore the protective …

Schistosomiasis is a tropical parasitic disease, in which the major clinical manifestation
includes hepatosplenomegaly, portal hypertension, and organs fibrosis. Clinically, treatment …